Skip to main content

RxNews®

Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.

Sandostatin® LAR Depot (octreotide) – First-time generic

October 1, 2024 - Teva launched an AB-rated generic version of Novartis’ Sandostatin LAR Depot (octreotide) intramuscular injection.

Download PDF

Rx navigation